Dear RS Community members:
We are pleased to co-promote a very timely topic of the ongoing digital evolution in drug development. It is nice to hear about what is needed for regulatory acceptance of these new approaches.
Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Biomarkers and Precision Medicine (BPM) Community on the following topic:
Digital Biomarkers: Past, Present, and Future
· How are digital biomarkers being utilized to assess clinical outcomes and facilitate drug development?
· What initiatives are underway to help guide the validation and use of digital biomarkers?
· What challenges exist for the implementation of digital biomarkers?
· What are emerging applications for digital biomarkers and where is the field headed?
Discussion Leader:
Elena Izmailova (Koneska Health)
Organized by:
Lakshmi Amaravadi (Dewpoint Therapeutics), Carmen Fernández-Metzler (PharmaCadence), Karen Quadrini (Passage Bio)
We start at 12:00 EST sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.
(Please remain on mute unless asking questions)
When: Monday, May 1, 2023, 12 pm – 1 pm EST
Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893
You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 305-789-893
Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 305 789 893
Or dial directly: [email protected] or 67.217.95.2##305789893
New to GoToMeeting? Get the app now and be ready when your first meeting starts:
https://global.gotomeeting.com/install/305789893
Please listen, participate actively in this discussion. Also feel free to share with colleagues who may be interested in this topic.
Hope you enjoy the session !!
-Raja
Chair, RS Community
------------------------------
Raja Velagapudi Ph.D.
Sr. Director, Clinical Development
Tolmar Inc
Monmouth Junction NJ
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------